Table 2.
Combinative energy value of the effective components of SWJPs in the treatment of RA.
| Effective components | GAPD(H) | EGFR | CASP3 | HSP90AA1 | SRC | MAPK3 | 
|---|---|---|---|---|---|---|
| THSG | −9.9 | −5.2 | −8.0 | −6.8 | −3.9 | −8.2 | 
| EMO | −9.7 | −5.9 | −8.1 | −8.0 | −3.1 | −8.2 | 
| PHC | −9.6 | −5.7 | −7.9 | −7.2 | −3.9 | −9.2 | 
| BAC | −8.0 | −5.8 | −7.1 | −6.6 | −5.0 | −8.0 | 
| BHA | −8.5 | −5.6 | −7.1 | −6.4 | −4.5 | −8.4 | 
| BMA | −7.6 | −5.7 | −6.9 | −6.3 | −4.3 | −7.7 | 
| βBA | −8.6 | −5.9 | −8.4 | −7.3 | −4.0 | −8.9 | 
| βABA | −8.5 | −6.2 | −9.1 | −7.2 | −3.7 | −8.3 |